- Home
- ENLV vs MTEX Comparison
ENLV vs MTEX Comparison
Compare ENLV & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- MTEX
- Stock Information
- Founded
- ENLV 2005
- MTEX 1993
- Country
- ENLV Israel
- MTEX United States
- Employees
- ENLV N/A
- MTEX N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- ENLV Health Care
- MTEX Health Care
- Exchange
- ENLV Nasdaq
- MTEX Nasdaq
- Market Cap
- ENLV 20.7M
- MTEX 21.2M
- IPO Year
- ENLV 1995
- MTEX 1999
- Fundamental
- Price
- ENLV $0.88
- MTEX $7.93
- Analyst Decision
- ENLV Strong Buy
- MTEX
- Analyst Count
- ENLV 2
- MTEX 0
- Target Price
- ENLV $10.00
- MTEX N/A
- AVG Volume (30 Days)
- ENLV 141.4K
- MTEX 4.6K
- Earning Date
- ENLV 04-15-2025
- MTEX 05-13-2025
- Dividend Yield
- ENLV N/A
- MTEX N/A
- EPS Growth
- ENLV N/A
- MTEX N/A
- EPS
- ENLV N/A
- MTEX 1.32
- Revenue
- ENLV N/A
- MTEX $117,866,000.00
- Revenue This Year
- ENLV N/A
- MTEX N/A
- Revenue Next Year
- ENLV N/A
- MTEX N/A
- P/E Ratio
- ENLV N/A
- MTEX $6.38
- Revenue Growth
- ENLV N/A
- MTEX N/A
- 52 Week Low
- ENLV $0.81
- MTEX $6.75
- 52 Week High
- ENLV $4.43
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- ENLV 39.11
- MTEX 25.06
- Support Level
- ENLV $0.92
- MTEX $8.21
- Resistance Level
- ENLV $1.13
- MTEX $9.20
- Average True Range (ATR)
- ENLV 0.08
- MTEX 0.43
- MACD
- ENLV -0.02
- MTEX -0.13
- Stochastic Oscillator
- ENLV 3.12
- MTEX 0.00
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.